- Xi tells Biden ready for 'smooth transition' to Trump
- Trump nominates fracking magnate and climate skeptic as energy secretary
- Tyson says 'no regrets' over loss for fighting 'one last time'
- Springboks' Erasmus hails 'special' Kolbe after England try double
- France edge out New Zealand in Test thriller
- Xi tells Biden will seek 'smooth transition' in US-China ties
- Netherlands into Nations League quarter-finals as Germany hit seven
- Venezuela to free 225 detained in post-election unrest: source
- Late Guirassy goal boosts Guinea in AFCON qualifying
- Biden arrives for final talks with Xi as Trump return looms
- Dominant Sinner cruises into ATP Finals title decider with Fritz
- Dinosaur skeleton fetches 6 million euros in Paris sale
- Netherlands-Hungary Nations League match interrupted by medical emergency
- Kolbe double as South Africa condemn England to fifth successive defeat
- Kolbe at the double as South Africa condemn England to fresh defeat
- Kolbe at the double as South Africa beat England 29-20
- 'If I don't feel ready, I won't play singles,' says Nadal ahead of Davis Cup farewell
- Fifth of dengue cases due to climate change: researchers
- Trump's Republican allies tread lightly on Paris pact at COP29
- Graham equals record as nine-try Scotland see off tenacious Portugal
- Protesters hold pro-Palestinian march in Rio ahead of G20
- Graham equals record as nine-try Scotland see off dogged Portugal
- China's Xi urges APEC unity in face of 'protectionism'
- Japan's Kagiyama, Yoshida sweep gold in Finland GP
- Macron to press Milei on climate action, multilateralism in Argentina talks
- Fritz reaches ATP Finals title decider with Sampras mark in sight
- All eyes on G20 for breakthrough as COP29 climate talks stall
- Fritz battles past Zverev to reach ATP Finals title decider
- Xi, Biden to meet as Trump return looms
- Kane warns England must protect team culture under new boss
- Italy beat Japan to reach BJK Cup semi-finals
- Farmers target PM Starmer in protest against new UK tax rules
- Shiffrin masters Levi slalom for 98th World Cup win
- Italy's Donnarumma thankful for Mbappe absence in France showdown
- McIlroy in three-way tie for Dubai lead
- Bagnaia wins Barcelona MotoGP sprint to take season to final race
- Ukraine's Zelensky says wants to end war by diplomacy next year
- Shiffrin wins Levi slalom for 98th World Cup victory
- Israel pummels south Beirut as Lebanon mulls truce plan
- Religious Jews comfort hostages' families in Tel Aviv
- German Greens' Robert Habeck to lead bruised party into elections
- Johnson bags five as Australia beat Pakistan to seal T20 series
- Zelensky says wants to end war by diplomacy next year
- Rugby Union: Wales v Australia - three talking points
- 10 newborns killed in India hospital fire
- Veteran Le Cam leads Vendee Globe as Sorel is first to quit
- Bagnaia on pole for Barcelona MotoGP, Martin fourth
- UN climate chief urges G20 to spur tense COP29 negotiations
- Rauf takes four as Pakistan hold Australia to 147-9 in 2nd T20
- World not listening to us, laments Kenyan climate scientist at COP29
US panel recommends nonprescription use of contraception pill
A US panel of health experts voted Wednesday in favor of making birth control pills available without a prescription, a move backed by reproductive rights advocates especially in the wake of a Supreme Court ruling overturning the national right to abortion.
The independent panel voted unanimously that the benefits of allowing the medicine, Opill, to be sold over the counter, outweighed the risks and would reduce hurdles associated with visiting a doctor that impact lower income groups disproportionately.
"I believe that the efficacy and safety of this birth control form was established over half a century ago," said panelist Jolie Haun of the James A. Haley Veterans' Hospital.
"We now have been presented with ample data demonstrating the effective safe use and benefits for people who want to have access to reproductive autonomy."
The committee's votes are usually accepted by the Food and Drug Administration, which means the pill, which is made by HRA Pharma, might be available without prescription in the coming weeks.
While likely, approval is not assured. FDA scientists highlighted safety concerns, such as the potential impact on people with a history or current diagnosis of breast cancer, or whether they would understand the pill needs to be taken the same time every day to prevent pregnancy.
"There is also concern that some consumers may not consistently use the product correctly on a chronic basis and be at risk for pregnancy, but not recognize that they are pregnant because of the irregular bleeding that would be ascribed to the known side effect," the FDA wrote in a document.
The push for a non-prescription pill has taken on new urgency in light of a Supreme Court decision overturning the constitutional right to abortion, leading to numerous bans and severe restrictions in conservative states.
It has received support from health groups such as the American Medical Association and American College of Obstetricians and Gynecologists.
If the pill is approved, the US would join more than 100 other countries where the pill is available without a prescription, including the UK which requires a consultation with a pharmacist.
Opill is known as a "mini pill" because it contains progestin only.
Another company, Cadence, is in talks with the FDA about making its combination pill, which contains both estrogen and progestin, available over the counter.
P.A.Mendoza--AT